Cannabis Stocks: If the Rally Isn’t Over, This 1 Looks Attractive

Here’s why Tilray (TSX:TLRY)(NASDAQ:TLRY) remains one of the top cannabis stocks long-term growth investors may want to watch right now.

Once one of the most-discussed sectors among growth investors, interest in cannabis stocks has waned substantially of late. Indeed, the question of whether retail investors will once again jump on perhaps the “greenest” sector of them all remains to be seen.

Among the cannabis stocks that has been losing momentum of late is Tilray (TSX: TLRY)(NASDAQ: TLRY), fresh of its merger with Aphria. Indeed, as the world’s largest cannabis company (for now), investors will be keeping a close eye on how this company performs moving forward.

Here’s one of the key reasons why Tilray may be one of the Canadian cannabis stocks worth watching right now.

Big U.S. investment puts cannabis stocks back on watch

In addition to Tilray’s massive Aphria merger, there’s another deal that’s grabbing headlines of late. The company recently made a big move to potentially acquire its way into the U.S. market.

Indeed, the potential for Federal legalization in the U.S. looms over cannabis stocks. Should cannabis become legal for recreational use, it’s expected that a rising tide could lift all boats. Accordingly, it appears Tilray is doing its best to be in the water when the tide rises.

By acquiring more than US$165 million of debt in MedMen Enterprises, experts believe Tilray may be making an acquisition run at MedMen. After all, this is a massive investment. It’s understandable that this kind of investment in another company’s debt would preclude an equity investment.

Additionally, this debt is convertible to equity. This means that should Tilray exercise its right to convert this debt to shares, the mega-cap cannabis player could own more than 20% of the voting shares of MedMen.

On top of this, Tilray’s CEO has publicly stated that acquiring MedMen isn’t out of the question. Thus, investors banking on further consolidation certainly have reason to believe there’s more than just smoke with this transaction.

Tilray’s gateway to the U.S. cannabis market

MedMen’s status as one of the preeminent retail chains of U.S. cannabis stores in California, Illinois, Massachusetts, and Nevada is a big deal. Indeed, the vertical integration that MedMen could provide Tilray appears to be a focal point for Tilray’s CEO in terms of his plans to integrate this company into the U.S. market.

Indeed, Tilray appears to be betting on some sort of legalization legislation to proceed forward soon. By getting ahead of the news, Tilray looks to be positioning itself as a key potential player in the U.S. cannabis supply chain. While other cannabis stocks appear to be focused more on their domestic markets, Tilray is aggressively looking at expanding.

For long-term growth investors, perhaps such as strategy will pay off. Indeed, only time will tell. However, for now, Tilray certainly looks enticing. That is, for those who think cannabis stocks still have a long growth runway from here.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

Top Canadian Stocks to Buy Right Now With $1,000

Cannara, Source Energy and CareRx just updated investors. See what $1,000 can buy in these Canadian stocks, plus the risks…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

This Cannabis Stock Jumped 12% in a Day: The Math Says Be Careful

Tilray's record revenue came with declining cannabis sales and negative free cash flow, making the investment much more speculative than…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf’s Takeover Bid for Aurora Cannabis: What Investors Need to Know

Curaleaf's takeover bid for Aurora Cannabis offers a premium but brings stock, debt, and deal risks. Here’s what ACB investors…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors.

It's appealing directly to the Canadian company's shareholders with a cash-and-stock offer.

Read more »

runner checks her biodata on smartwatch
Cannabis Stocks

Average TFSA and RRSP Balances at Age 45: Are You on Par?

Most 45-year-olds have less than $100,000 combined in their TFSA and RRSP. Here's how TerrAscend could help you close the…

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Risky Stocks That Could Send Your $100,000 Investment to $0

Cannabis stocks look risky because price wars, dilution, and regulation can turn one weak quarter into a long drawdown.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

My Biggest Investing Regret in 2025 Was Buying This Stock

Canopy Growth is a cautionary reminder to buy businesses, not headlines, especially in hype-driven sectors like cannabis.

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg.

Read more »